PRICE T ROWE ASSOCIATES INC /MD/: XENE position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of PRICE T ROWE ASSOCIATES INC /MD/ on XENE, newest first. How the timeline and the estimate are built.
PRICE T ROWE ASSOCIATES INC /MD/ held 3,248,219 XENE shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 3,248,219 sharesChange vs previous 13F +1,918,628 shares
0.02% of the 13F portfolio, value $196,063,000.
13F-HR 0000080255-26-000519 filed by PRICE T ROWE ASSOCIATES INC /MD/
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 1,329,591 sharesChange vs previous 13F +467,291 shares
0.01% of the 13F portfolio, value $77,317,000.
13F-HR 0000080255-26-000381 filed by PRICE T ROWE ASSOCIATES INC /MD/
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 862,300 sharesChange vs previous 13F +820,608 shares
<0.01% of the 13F portfolio, value $38,650,000.
13F-HR 0000080255-26-000231 filed by PRICE T ROWE ASSOCIATES INC /MD/
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 41,692 sharesChange vs previous 13F +3,757 shares
<0.01% of the 13F portfolio, value $1,675,000.
13F-HR 0000080255-25-000782 filed by PRICE T ROWE ASSOCIATES INC /MD/
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 37,935 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $1,189,000.
13F-HR 0000080255-25-000547 filed by PRICE T ROWE ASSOCIATES INC /MD/
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).